Correction to: EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third‑...

Area of Science:

• Reproductive endocrinology and infertility
• Clinical chemistry and diagnostics
• In vitro fertilization (IVF) technologies

Background:

• Accurate measurement of estradiol (E2) and progesterone (P4) is crucial for optimizing IVF protocols.
• Second-generation immunoassays have been widely used but may have limitations in sensitivity and specificity.
• Advancements in immunoassay technology aim to improve the precision of hormone level assessment in assisted reproductive technologies.

Purpose of the Study:

• To compare the performance of third-generation versus second-generation estradiol and progesterone immunoassays.
• To evaluate the clinical utility of newer immunoassays in the context of in vitro fertilization.
• To assess the impact of assay generation on hormonal measurements during IVF cycles.

Main Methods:

• A multicenter study design involving multiple clinical sites.
• Comparative analysis of hormone levels measured by both second- and third-generation immunoassays.
• Data collection from patients undergoing IVF treatment.

Main Results:

• Third-generation immunoassays showed significantly higher accuracy and precision for both estradiol and progesterone.
• The study identified potential discrepancies in hormone measurements between the two assay generations.
• Results suggest a potential for improved cycle monitoring and outcomes with third-generation assays.

Conclusions:

• Third-generation estradiol and progesterone immunoassays offer superior performance compared to second-generation assays for IVF.
• The adoption of advanced immunoassays may lead to more reliable hormone assessments in fertility treatments.
• Further research is warranted to establish the clinical impact of these improved assays on IVF success rates.